MoleSense raises CHF 100,000

MoleSense is developing a skin patch that continuously monitors biomarkers to track high-risk pregnancies. The FIT has granted it a CHF 100,000 Tech Seed loan to build a first prototype and carry out preclinical testing.

Announced on
Round
Loan
Amount
CHF 100,000
Location
Epalinges, canton of Vaud
Sector
Health & medtech

Investors

Preparing a similar round?

The diagnostic shows you the instruments and investors that fit your stage.

Start the diagnostic